These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23084271)

  • 1. An analysis of security price risk and return among publicly traded pharmacy corporations.
    Gilligan AM; Skrepnek GH
    Res Social Adm Pharm; 2013; 9(6):828-40. PubMed ID: 23084271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What stock market returns to expect for the future?
    Diamond PA
    Soc Secur Bull; 2000; 63(2):38-52. PubMed ID: 11131980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public option and private profits: what do markets expect?
    Milani F
    Appl Health Econ Health Policy; 2010; 8(3):155-65. PubMed ID: 20201607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractal dimension analysis of stock prices of selected resulting companies after mergers and acquisitions.
    Verma SK; Kumar S
    Eur Phys J Spec Top; 2023 May; ():1-11. PubMed ID: 37359185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the partitioned multiobjective risk method (PMRM) to portfolio selection.
    Reyes Santos J; Haimes YY
    Risk Anal; 2004 Jun; 24(3):697-713. PubMed ID: 15209939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An augmented capital asset pricing model using new macroeconomic determinants.
    Pham CD; Phuoc LT
    Heliyon; 2020 Oct; 6(10):e05185. PubMed ID: 33102838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
    Stargardt T; Schreyögg J; Busse R
    Health Policy; 2007 Nov; 84(1):30-8. PubMed ID: 17553587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Security: a financial appraisal for the median voter.
    Galasso V
    Soc Secur Bull; 2001-2002; 64(2):57-65. PubMed ID: 12428510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sign realized jump risk and the cross-section of stock returns: Evidence from China's stock market.
    Chao Y; Liu X; Guo S
    PLoS One; 2017; 12(8):e0181990. PubMed ID: 28771514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilizing effect of volatility in financial markets.
    Valenti D; Fazio G; Spagnolo B
    Phys Rev E; 2018 Jun; 97(6-1):062307. PubMed ID: 30011541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012.
    Schommer JC; Yusuf AA; Hadsall RS
    Res Social Adm Pharm; 2014; 10(1):217-31. PubMed ID: 23669250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's your real cost of capital?
    McNulty JJ; Yeh TD; Schulze WS; Lubatkin MH
    Harv Bus Rev; 2002 Oct; 80(10):114-21, 130. PubMed ID: 12389465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States Stock Market Response to FDA Approval of New Dermatologic Drugs.
    Mazmudar RS; Tripathi R; Ezaldein HH; Scott JF
    J Drugs Dermatol; 2020 Jun; 19(6):639-645. PubMed ID: 32574024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profitability and risk-return comparison across health care industries, evidence from publicly traded companies 2010-2019.
    Bai G; Rajgopal S; Srivastava A; Zhao R
    PLoS One; 2022; 17(11):e0275245. PubMed ID: 36383519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entropy-based financial asset pricing.
    Ormos M; Zibriczky D
    PLoS One; 2014; 9(12):e115742. PubMed ID: 25545668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of information release on return volatility: A market and sectoral analysis.
    Prasad M; Bakry W; Varua ME
    Heliyon; 2020 May; 6(5):e03885. PubMed ID: 32490224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for non-Gaussian intraday stock returns.
    Gerig A; Vicente J; Fuentes MA
    Phys Rev E Stat Nonlin Soft Matter Phys; 2009 Dec; 80(6 Pt 2):065102. PubMed ID: 20365214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wall Street's assessment of plastic surgery--related technology: a clinical and financial analysis.
    Krieger LM; Shaw WW
    Plast Reconstr Surg; 2000 Feb; 105(2):609-16. PubMed ID: 10697168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
    Douven RC; Schut FT
    J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does news affect biopharma stock prices?: An event study.
    Cho J; Singh M; Lo AW
    PLoS One; 2024; 19(1):e0296927. PubMed ID: 38277362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.